Mark J. Roth
Impact in
- Cancer Research top 2%
- Oncology top 5%
Papers in
-
- Cancer-related gene regulation 13
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 8
- Surgery 31
- Esophageal Cancer Research and Treatment 23
- Esophageal and GI Pathology 6
- Co-authors
- Sanford M. Dawsey (42 shared papers)Michael R. Emmert‐Buck (18 shared papers)Philip R. Taylor (39 shared papers)Lance A. Liotta (3 shared papers)You‐Lin Qiao (22 shared papers)Verena E. Bichsel (2 shared papers)Cloud P. Paweletz (2 shared papers)John W. Gillespie (2 shared papers)
- Journals
- Cancer Epidemiology Biomarkers & Prevention (7 papers)Genes Chromosomes and Cancer (5 papers)Cancer (3 papers)Blood (3 papers)Human Pathology (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Mark J. Roth
89 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 775
- Oncology 760
- Molecular Biology 1.9k
- Otorhinolaryngology 112
- Surgery 1.1k
Countries citing papers authored by Mark J. Roth
This map shows the geographic impact of Mark J. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Roth more than expected).
Fields of papers citing papers by Mark J. Roth
This network shows the impact of papers produced by Mark J. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Roth. The network helps show where Mark J. Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front Hit paper breakdown → | 2001 | 746 |
| 2 | 1998 | 246 | |
| 3 | Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. | 1994 | 197 |
| 4 | Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. | 2000 | 195 |
| 5 | 2003 | 148 | |
| 6 | 2012 | 141 | |
| 7 | 2012 | 118 | |
| 8 | 2001 | 100 | |
| 9 | High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. | 2005 | 95 |
| 10 | 2000 | 93 | |
| 11 | Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections. | 1995 | 93 |
| 12 | Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. | 1999 | 85 |
| 13 | 2005 | 76 | |
| 14 | 1997 | 69 | |
| 15 | 2004 | 65 | |
| 16 | Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. | 2003 | 63 |
| 17 | 2009 | 61 | |
| 18 | Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. | 2001 | 57 |
| 19 | 2006 | 56 | |
| 20 | 2006 | 54 |
About Mark J. Roth
Mark J. Roth is a scholar working on Molecular Biology, Surgery, Cancer Research, Oncology and Epidemiology, having authored 90 papers that have together received 4.2k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (23 papers), Cancer-related gene regulation (13 papers), Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (8 papers), Carcinogens and Genotoxicity Assessment (8 papers), Esophageal and GI Pathology (6 papers), Genetic factors in colorectal cancer (5 papers) and Maternal Mental Health During Pregnancy and Postpartum (5 papers). The work is most often cited by research in Cancer Research (775 citations), Oncology (760 citations), Molecular Biology (1.9k citations), Otorhinolaryngology (112 citations) and Surgery (1.1k citations). Mark J. Roth has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Sanford M. Dawsey, Michael R. Emmert‐Buck, Philip R. Taylor, Lance A. Liotta, You‐Lin Qiao, Verena E. Bichsel, Cloud P. Paweletz, John W. Gillespie, Emanuel F. Petricoin and Lu Charboneau. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Genes Chromosomes and Cancer, Cancer, Blood and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.